Clinical Report: Lateral Ventricular Lesion as a Presentation of Von Hippel-Lindau Syndrome

Background

Von Hippel-Lindau disease is a rare autosomal dominant disorder characterized by the development of various tumors and cysts due to mutations in the VHL tumor suppressor gene. Diagnosis can be challenging due to its multisystemic nature, and genetic testing is now considered the gold standard for diagnosis. Understanding VHL is crucial for timely diagnosis and management to prevent severe complications.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• The patient was diagnosed with VHL syndrome after presenting with an intracranial space-occupying lesion.
• Imaging revealed a collision tumor consisting of a lateral ventricular hemangioblastoma and metastatic clear cell renal cell carcinoma.
• Postoperative complications included extensive intracranial hemorrhage and fatal brainstem hemorrhage attributable to the surgery.
• VHL syndrome is associated with a variety of tumors, including hemangioblastomas and renal cell carcinoma.
• Genetic testing is essential for the diagnosis of VHL syndrome.

Clinical Implications

This case highlights the importance of early detection and management of VHL syndrome. Clinicians should maintain a high index of suspicion for VHL in patients presenting with relevant symptoms.

Conclusion

The complexities of VHL syndrome necessitate careful management, particularly in cases involving central nervous system lesions.

Related Resources & Content

1. Frontiers in Oncology, 2026 -- Case Report: Diagnosis and treatment report and literature review of 2 cases of VHL-deficient renal cell carcinoma
2. Journal of Neuro-Oncology, 2006 -- Hemangioblastomatosis in a patient with von Hippel-Lindau disease
3. Frontiers in Medicine, 2026 -- Parapapillary retinal hemangioblastoma presenting as an epiretinal membrane in a patient with Von Hippel–Lindau disease: a case report
4. Von Hippel-Lindau Disease (PDQ®) - NCI
5. the asco post — I Haven’t Known a Life Without von Hippel-Lindau Disease
6. Von Hippel-Lindau Disease (PDQ®) - NCI
7. Stereotactic radiosurgery in the management of central nervous system hemangioblastomas: a systematic review and meta-analysis - PMC
8. Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease | New England Journal of Medicine